SB
Samsara BioCapital’s Arcellx ACLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.68M | Sell |
101,457
-33,819
| -25% | -$2.23M | 1.37% | 12 |
|
|
2025
Q1 | $8.87M | Sell |
135,276
-118,365
| -47% | -$7.76M | 1.58% | 11 |
|
|
2024
Q4 | $19.5M | Sell |
253,641
-100,000
| -28% | -$7.67M | 2.67% | 9 |
|
|
2024
Q3 | $29.5M | Sell |
353,641
-100,000
| -22% | -$8.35M | 5.68% | 6 |
|
|
2024
Q2 | $25M | Hold |
453,641
| – | – | 5.24% | 5 |
|
|
2024
Q1 | $31.6M | Sell |
453,641
-6,800
| -1% | -$473K | 4.88% | 6 |
|
|
2023
Q4 | $25.6M | Sell |
460,441
-153,480
| -25% | -$8.52M | 3.98% | 5 |
|
|
2023
Q3 | $22M | Hold |
613,921
| – | – | 6.74% | 5 |
|
|
2023
Q2 | $19.4M | Sell |
613,921
-295,658
| -33% | -$9.35M | 3.41% | 6 |
|
|
2023
Q1 | $28M | Sell |
909,579
-47,872
| -5% | -$1.47M | 5.79% | 4 |
|
|
2022
Q4 | $29.7M | Sell |
957,451
-106,384
| -10% | -$3.3M | 6.38% | 3 |
|
|
2022
Q3 | $20M | Hold |
1,063,835
| – | – | 4.66% | 6 |
|
|
2022
Q2 | $19.2M | Buy |
1,063,835
+64,108
| +6% | +$1.16M | 5.13% | 5 |
|
|
2022
Q1 | $14M | Buy |
+999,727
| New | +$14M | 3.53% | 8 |
|